Privi Speciality Chemicals Gets US FDA Certification for Camphor Product

MT Newswires Live

2024/10/11

Privi Speciality Chemicals (NSE:PRIVISCL, BOM:530117) has received a Certificate of Active Pharmaceuticals Ingredient Product Listing and a Certificate of Registration for its Camphor product from the US Food and Drug Administration.

The company already has a license to manufacture and sell Camphor in India from the Food and Drugs Administration, Maharashtra State, which allows it to sell the product to Indian pharmaceutical companies.

With this latest certification, the company can expand in the area of pharmaceutical applications in the US.

Price (INR): â¹1587.90, Change: â¹+33, Percent Change: +2.14%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2474080038"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2474080038\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2474080038?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-11 11:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474080038","market":"nz","top_or_hot":-1,"title":"Privi Speciality Chemicals Gets US FDA Certification for Camphor Product","media":"MT Newswires Live","content":"<html><body><p> Privi Speciality Chemicals (NSE:PRIVISCL, BOM:530117) has received a Certificate of Active Pharmaceuticals Ingredient Product Listing and a Certificate of Registration for its Camphor product from the US Food and Drug Administration.</p><p>The company already has a license to manufacture and sell Camphor in India from the Food and Drugs Administration, Maharashtra State, which allows it to sell the product to Indian pharmaceutical companies.</p><p>With this latest certification, the company can expand in the area of pharmaceutical applications in the US.</p><p>Price (INR): â¹1587.90, Change: â¹+33, Percent Change: +2.14%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Privi Speciality Chemicals Gets US FDA Certification for Camphor Product</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPrivi Speciality Chemicals Gets US FDA Certification for Camphor Product\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-10-11 11:38</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Privi Speciality Chemicals (NSE:PRIVISCL, BOM:530117) has received a Certificate of Active Pharmaceuticals Ingredient Product Listing and a Certificate of Registration for its Camphor product from the US Food and Drug Administration.</p><p>The company already has a license to manufacture and sell Camphor in India from the Food and Drugs Administration, Maharashtra State, which allows it to sell the product to Indian pharmaceutical companies.</p><p>With this latest certification, the company can expand in the area of pharmaceutical applications in the US.</p><p>Price (INR): â¹1587.90, Change: â¹+33, Percent Change: +2.14%</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INR","symbol_name":"Infinity Natural Resources","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2474080038","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474080038","pubTimestamp":1728617894,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Privi Speciality Chemicals  has received a Certificate of Active Pharmaceuticals Ingredient Product Listing and a Certificate of Registration for its Camphor product from the US Food and Drug Administration.The company already has a license to manufacture and sell Camphor in India from the Food and Drugs Administration, Maharashtra State, which allows it to sell the product to Indian pharmaceutical companies.With this latest certification, the company can expand in the area of pharmaceutical applications in the US.Price : 1587.90, Change: +33, Percent Change: +2.14%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INR":"Infinity Natural Resources","BK6100":"保健护理服务","BK6520":"工商业服务概念","INR.AU":"IONEER LTD","BK7095":"多种金属与采矿","OTX.SI":"迈怡汇有限公司","BK7504":"锂钴概念"},"translate_title":"Privi Speciality Chemicals樟脑产品获得美国FDA认证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INR":1,"INR.AU":1,"OTX.SI":1},"content_text":"Privi Speciality Chemicals (NSE:PRIVISCL, BOM:530117) has received a Certificate of Active Pharmaceuticals Ingredient Product Listing and a Certificate of Registration for its Camphor product from the US Food and Drug Administration.The company already has a license to manufacture and sell Camphor in India from the Food and Drugs Administration, Maharashtra State, which allows it to sell the product to Indian pharmaceutical companies.With this latest certification, the company can expand in the area of pharmaceutical applications in the US.Price (INR): â¹1587.90, Change: â¹+33, Percent Change: +2.14%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}